Etanercept in the treatment of disease-modifying anti-rheumatic drug (DMARD)-refractory polyarticular course juvenile idiopathic arthritis: experience from Japanese clinical trials.
about
Efficacy, pharmacokinetics, and safety of adalimumab in pediatric patients with juvenile idiopathic arthritis in Japan.Etanercept: a review of its use in autoimmune inflammatory diseases.Safety and effectiveness of etanercept for treatment of juvenile idiopathic arthritis: Results from a postmarketing surveillance.Safety and efficacy of long-term etanercept in the treatment of methotrexate-refractory polyarticular-course juvenile idiopathic arthritis in Japan.
P2860
Etanercept in the treatment of disease-modifying anti-rheumatic drug (DMARD)-refractory polyarticular course juvenile idiopathic arthritis: experience from Japanese clinical trials.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Etanercept in the treatment of ...... from Japanese clinical trials.
@en
Etanercept in the treatment of disease-modifying anti-rheumatic drug
@nl
type
label
Etanercept in the treatment of ...... from Japanese clinical trials.
@en
Etanercept in the treatment of disease-modifying anti-rheumatic drug
@nl
prefLabel
Etanercept in the treatment of ...... from Japanese clinical trials.
@en
Etanercept in the treatment of disease-modifying anti-rheumatic drug
@nl
P2093
P2860
P1433
P1476
Etanercept in the treatment of ...... from Japanese clinical trials.
@en
P2093
Hirotoshi Yuasa
Hiroyuki Imanaka
Joseph S Wajdula
Masaaki Mori
Noriko Sugiyama
Rumiko Kurosawa
Shumpei Yokota
Syuji Takei
Tomoyuki Imagawa
Tracey Fletcher
P2860
P304
P356
10.3109/S10165-011-0450-7
P577
2011-04-11T00:00:00Z